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Abstract
Background: A wide variety of probiotic products has been introduced into the market in the past decade.
Research trends and activity on probiotics help understand how these products were evolved and their potential
future role in medicine. The objective of this study was to assess the research activity on probiotics in pediatrics
using bibliometric indicators and network visualization.
Methods: Original and review articles on probiotics in pediatrics published worldwide were retrieved from SciVerse,
Scopus (1994–2014) and analyzed. VOSviewer was used for network visualization.
Results: The total number of documents published on probiotics in pediatrics was 2817. Research activity on
probiotics in pediatrics showed approximately 90- fold increase during the study period. Approximately 22 % of
published articles originated from USA and has the greatest share, however, Finland ranked first when data were
stratified by population or income. The most productive institution in this field was Turku University in Finland
with 82 (2.91 %) articles. Half of the prolific authors were also from Finland. Most of the published research activity
appeared in Journal of Pediatric Gastroenterology and Nutrition. Most frequently encountered title terms include
nutrition, infant formula, necrotizing enetrocolitis, allergy, and diarrhea. The total number of citations for the
retreived documents documents was 70991, and the average citation per article was 25.20.
Conclusions: Interest in probiotic research and its potential benefits in pediatric ailments is relatively recent but
significantly increasing. Bibliometric analysis can be used as an indicator of the importance and growth of probiotic
use in pediatrics.
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Background
Probiotics are defined as live microbes which can benefit
the host when consumed in sufficient amounts [1, 2].
Probiotics have been described as friendly bacteria with
host benefits [3]. Common probiotics include species
with the genera Lactobacillus and Bifidobacteria which
can be found in some commercial dairy products and
cereals [1, 2]. Probiotic products are available in the
market and interest of consumers and clinicians in these
products is growing as evident by the tremendous
increase in the sale of these products over a short period
of time [4, 5]. The friendly nature of these products and
their classification as dietary supplements has increased
the popularity and marketability of these products. The
potential benefits of the gut microbiota on immune
function encouraged researchers to investigate potential
health effects of gut microbiota [6]. Furthermore, the
diversity of health conditions claimed to be treated by
probiotics made clinicians and researchers keen to inves-
tigate and learn more about these relatively safe and
natural products. Some conditions that probiotics might
benefit include inflammatory bowel disease (IBD),
irritable bowel syndrome (IBS), antibiotic-associated
diarrhea (AAD), necrotizing enterocolitis (NEC), and other
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conditions [7–9]. Better understanding of research trends
in any medical field requires a full understanding of the
research activity in that field and the key researchers and
institutes in that particular field. Such understanding of
the research activity could be achieved through biblio-
metric analysis using well known databases. In the case of
probiotics, and up to the author’s best knowledge, no
bibliometric studies on probiotics in pediatrics have been
published. Therefore, we sought to assess trends in re-
search activity about probiotics in pediatrics. This is
important for future comparative analysis on probiotics
research. Such bibliometric and comparative information
are important for clinicians, health policy makers, con-
sumers and manufacturers given that safety and efficacy
of probiotics for health problems in infants and children
are not yet well established.
Methods
The data in this study were synthesized using Scopus
database which has many important features that facili-
tate bibliometric analysis as in previous similar studies
[10–15]. Such features include citation analysis, country
and author contribution as well as source titles and
productivity per year. Scopus is produced by Elsevier
and covers more than 20,000 journals that have 100 %
Medline coverage. Scopus is larger than Web of Science
and more accurate than Google Scholar [16].
The study period was set from January 01, 1994 to
December 31, 2014. All subject areas in Scopus search
engine (life sciences, social sciences, health and physical
sciences) were chosen. The date for the study was set up
to 2014 because data for 2015 and 2016 are not yet
complete in Scopus since some journal may require 1–
2 years to transfer its content to databases. Therefore,
inclusion of 2015 and 2016 will create some inaccuracy
problems. The search strategy in this article was based
on retrieving articles with the keyword probiotics in
title-abstract-key and keywords relevant to the term
“pediatrics” in article title or keywords. All articles with
the keyword “adult” were excluded. To increase the
accuracy of our search, documents classified as errata,
or books, or book chapter or un-defined type of docu-
ments were excluded and therefore this study is restricted
to documents that are considered journal articles. All
documents obtained after refining the results were trans-
ferred to Statistical Package for Social Sciences software
version 20 to present the bibliometric indicators. The
validity of our method was assessed by assessing the top
300 (~10 % of the results) cited documents retrieved by
the method mentioned above to assure that the content of
these retrieved articles matches the search query of
interest.
The main bibliometric indicators presented in this study
included type and language of the published documents,
country and institutional affiliation, source/ journal title in
which documents were published, most productive
authors, most cited articles, and collaboration patterns.
Many of the bibliometric indicators were presented in
rank order. Research productivity was assessed by the
quantity of publications while the total number of
citations was used to identify the most influential articles
in the field [17–22]. The impact factor (IF) of journals was
used as a measure of quality of journals and was obtained
from Thompson Reuters [23]. The Hirsch index (h-index)
was used to assess the quantity and quality of publications
per country or per institution or per author [24]. The re-
search productivity of different countries was normalized
using population size and national Gross Domestic Prod-
uct (GDP) retrieved from the online databases of the
World Bank [25].
Bibliometric maps and network visualization methods
were made using VOSviewer software [26]. Using the
VOSviewer and thresholds of minimally ten fractionally
counted articles for each term, density visualization maps
were generated for most frequently encountered terms in
title of retrieved articles. In these maps, most frequent
terms had dense colored cluster. For co-authorship ana-
lysis, a minimum number of 500 authors were selected in
VOSviewer program. Authors located within or close to a
large cluster are believed to have higher number of co-
authors suggestive of inter and intra country collaboration.
The methodology used in this study was similar to re-
cent bibliometric studies published by the same research
group using SciVerse Scopus [27–32]. All data and docu-
ments were extracted and analyzed on 12th of April,
2016. Since the data for this study was obtained from
electronic sources that are publicly available and not
pertaining to specific patients’ data or profile, IRB ethical
approval for the study was not required.
Results
General data
Based on the search strategy implemented, a total of 2817
articles were retrieved. Around half (50.76 %) of these
articles were original research (Table 1). The total number
of different languages encountered in the retrieved articles
was 25 and the primary language was English (2416,
85.76 %). Other encounterd languages like Spanish,
German, French, Polish Russian, Italian, Chinese Czech
and Dutch are shown in Table 2.
The total number of citations for the retrieved articles
was 70991 and the average citation per article was 25.20.
A total of 610 (21.65 %) retrieved articles were not cited
while 2207 (78.35 %) were cited at least once. As expected,
the zero citation was highest for articles published in 2014
compared to ones published in previous years. The
number of articles which received at least 50 citations was
364 articles (12.92 %).
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Most frequent terms
In mapping terms frequency network, from the 3737
terms, 112 terms met the threshold of ten times as a
minimum number of occurrences. Then 56 terms were
selected as relevant terms based on calculated relevance
score. Figure 1 shows the visualization network map of
most frequently encountered terms in the title of retrieved
articles. Based on the map, seven clusters were located:
cluster number one contained 11 terms with the term
nutrition as most frequent one; cluster number two
contained nine items with the terms formula/ infant
formula being most frequent; cluster number three con-
tained eight items with the term necrotizing enterocolitis
being most frequently encountered; cluster number four
contained eight items with the term enterocolitis being
most frequently encountered; cluster number five con-
tained eight items with term allergy being most frequently
encountered; cluster number six contained eight items
with the term childhood being most frequently encoun-
tered; and finally cluster number seven contained eight
items with the term diarrhea being most frequently
encountered (Fig. 1).
Publications with time
The majority of retrieved articles (2351; 83.46 %) were
published in the past decade (2005–2014). Table 3 shows
the number of retrieved articles per year. Figure 2 shows
the average citations per article and the number of pub-
lished articles over the study period. Articles published
before year 2000 had the highest average citations per
article.
Countries
Table 4 shows the top ten productive countries from a
total of 102 countries which contributed to the advance-
ment of research on probiotics in pediatrics. The USA
had the greatest share of publications was also the
leading country in the annual number of publications.
Publications from USA had the highest share of citations
(18665), however, publications from Finland had the
highest number of citations per article (87.10). When
countries were ranked based on the h-index of their
research activity on probiotics in pediatrics, USA ranked
first (69) followed by Italy (48) and Finland (46) (Table 4).
International (inter country) collaboration was also
shown in Table 4. Articles from USA (25.00 %) and
Poland (21.99 %) had the least percentage of inter-
country collaboration. For USA and Poland, more than
75 % of articles were published by domestic authors. On
the other hand, more than half (54.63 %) of articles from
Netherlands, for example, had co-authors from other
different countries. For the top 10 productive countries a
total of 629 (31.91 %) articles had multiple country affilia-
tions while the remaining (68.09 %) published articles
were publications from single country collaboration.
Authors
Professor Isolauri, E. from Finland and Professor
Szajewska, H. from Poland ranked first in the number of
publications with 68 (2.41 %) articles for each (Table 5).
Besides, Isolauri, E. ranked first in h-index. Of the most
prolific authors, five were from Finland, two were from
the USA, one from Poland, one from Belgium and one
from Italy. Density visualization of co-authorships using
authors as unit of analysis showed that co-authorships
were high and common among most prolific authors
(Fig. 3). Co-authorships is suggestive of domestic and
international collaboration. Authors who were remotely
located from clusters have relatively fewer co-authorships
and collaborations. In density visualization map, out of
7589 authors, 51 met the threshold of ten and out of 51,
43 were selected based on relevance score. The map
contained eight clusters: cluster number one contained
ten authors with Vanderplas, Y. having highest number of
co-authorships; cluster number two contained seven items
with Isoluri, E., Kalliomaki, M., and Salmenin, S. having
highest number of co-authorships; cluster number three
Table 1 Number and percentage of each type of published
articles on probiotics in pediatrics (1994–2014)
Type of document Number (%)
Article 1430 (50.76)
Review 822 (29.18)




Short survey 63 (2.24)
Article in Press 12 (0.43)
Table 2 Top 10 languages encountered in retrieved articles on
probiotics in pediatrics (1994–2014)
Rank Language Frequency (%)
1 English 2416 (85.76)
2 Spanish 72 (2.56)
3 German 71 (2.52)
4 French 68 (2.41)
5 Polish 58 (2.06)
6 Russian 37 (1.31)
7 Italian 34 (1.21)
8 Chinese 26 (0.92)
9 Czech 11 (0.39)
10 Dutch 9 (0.32)
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which contained 6 items with Shamir, I. having highest
number of co-authorships; cluster number four contained
five authors with Savilhati, E., Kuitunen, M., and Korpela,
R. having the highest number of co-authorships; cluster
number five contained authors with Szajewska, H. and
Guarino, A. having the highest number of co-authorships;
cluster number six with four authors with Manzoni, P.
having the highest number of co-authorships; cluster num-
ber seven contained four authors with Neu, J. and Walker,
W. having the highest number of co-authorships; and
finally cluster number eight contained two authors with
Rodriguez, J. having highest number of co-authorships.
Frequently cited articles
The top 10 cited articles about probiotics in pediatrics are
presented in Table 6 [33–42], Table 7 [43–52] and Table 8
[53–62] based on year intervals. The article which received
the highest citation was “Probiotics in primary prevention
of atopic disease: A randomised placebo-controlled trial”
authored by Kalliomäki et al. and published in 2001 in
Lancet journal. The article received a total of 1696
citations up to the time of analysis of data (April 12, 2016).
Institutions
The most research productive institution was Turun
yliopisto (i.e., University of Turku) in Finland with 82
(2.91 %) publications and an h-index of 34. Furthermore,
Turun yliopisto also ranked first in total citations 8095
(Table 9).
Journals
The retrieved articles were published in 151 different
journal names. A total of 454 (16.12 %) articles were
published in the top ten productive journals (Table 10).
Fig. 1 Map of frequently encountered title terms in retrieved articles on probiotics in pediatrics
Table 3 Number of published articles and citations on
probiotics in pediatrics
Year Number of documents
N = 2817 (%)
Total citation Citations/article
1994–1999 60 (2.13) 5376 89.60
2000 34 (1.21) 2263 66.56
2001 60 (2.13) 4605 76.75
2002 103 (3.66) 4922 47.79
2003 95 (3.37) 4412 46.44
2004 114 (4.05) 3686 32.33
2005 173 (6.14) 6455 37.31
2006 173 (6.14) 4906 28.36
2007 211 (7.49) 4836 27.66
2008 216 (7.67) 6355 29.42
2009 198 (7.03) 4198 21.20
2010 236 (8.38) 5514 23.36
2011 240 (8.52) 4324 18.02
2012 258 (9.16) 3738 14.49
2013 336 (11.93) 2901 8.63
2014 310 (11.00) 1607 5.18
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The journal that has the largest share of publications was
Journal of Pediatric Gastroenterology and Nutrition (n =
127). The journal that received the greatest number of
citations was also the Journal of Pediatric Gastroenterology
and Nutrition. However the of citations per article was
greatest for Journal of Allergy and Clinical Immunology
112.59) followed by Clinical and Experimental Allergy
journal (80.44). Table 10 also shows the impact factor
values for the top ten productive journals.
Discussion
In the current study, we focused on 2817 published articles
on probiotic in pediatrics. These articles were retrieved
using Scopus database which is a large and trustful
database. All articles about probiotics published in other
databases like pubmed are also found in Scopus. Therefore,
using other databases will not change the results. However
articles about probiotics that are not indexed in any
database such as articles published in local journal in
Fig. 2 Evolution of the number of published articles and citations per article
Table 4 Top 10 productive countries in number of probiotics in pediatrics publications
SCRa Country Articles

















1st USA 616 (22.36) 19.32 (9) 35.36 (10) 18665 (1) 30.30 (6) 69 (1) 61 154 (25.00)
2nd Italy 265 (8.98) 43.2 (4) 123.77 (3) 8093 (3) 30.54 (5) 48 (2) 45 81 (30.57)
3rd United
Kingdom
167 (6.26) 25.89 (7) 55.87 (7) 7409 (4) 44.37 (3) 45 (4) 52 66 (39.52)
4th Germany 155 (5.14) 19.16 (10) 40.07 (9) 4982 (6) 32.14 (4) 42 (5) 43 67 (43.23)
5th Poland 141 (5.00) 37.11 (5) 258.72 (2) 3664 (7) 25.99 (9) 29 (9) 29 31 (21.99)
6th Finland 136 (4.86) 248.90 (1) 499.63 (1) 11845 (2) 87.10 (1) 46 (3) 38 44 (32.35)
7th France 132 (4.48) 19.94 (8) 46.66 (8) 3622 (8) 27.44 (8) 30 (7) 40 50 (37.88)
7th Spain 132 (4.48) 28.45 (6) 95.58 (5) 2537 (10) 19.20 (10) 25 (10) 37 38 (28.88)
9th Australia 119 (4.34) 50.66 (3) 81.79 (6) 3333 (9) 28.01 (7) 30 (7) 40 39 (32.77)
10th Netherlands 108 (4.26) 64.09 (2) 122.82 (4) 5212 (5) 48.26 (2) 37 (6) 45 59 (54.63)
Abbreviations: SCR standard competition ranking, USA United States of America, GDP gross domestic product
aEqual countries have the same ranking number, and then a gap is left in the ranking numbers
bPercentage of documents with international authors from the total number of documents for each country
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developing countries that are not indexed in Scopus could
have been missed. Overall, we consider the results obtained
are accurate and valid since manual review of 10 % of the
top cited articles showed that all articles were on probiotics
in pediatrics.
Although the history on probiotics research goes back
to the early 20th century [63], scientific research on pro-
biotics in pediatrics was first published in 1993 [64, 65].
Evidence – based management of pediatric illnesses such
as diarrhea, allergy and other ailments requires an un-
derstanding of how scientific research about various
medications has progressed. One method to assess past
and current status of medications is to assess research
output for that particular medication. In case of probio-
tics, the number of clinical trials investigating both the
efficacy and safety of probiotic products has increased
exponentially with great evidence of safety but varying
degrees of efficacy depending on the strain and medical
condition being treated [3, 8, 66].
The number of published articles in this field has in-
creased by greater than 90-fold during the past 20 years.
The growth in probiotic research is accompanied by an
overall increase in various medical and biomedical fields,
an increase in the number of journals particularly in the
field of pediatrics, and finally by the advancement in
microbiology. The presence of articles with non-English
language is also an indicator of worldwide growing inter-
est in probiotics. The noticable increase in publications
suggests that there is a large general audience for pro-
biotics as a means of therapy for pediatric aliments. The
Table 5 Top 10 authors publishing on probiotics in pediatrics
Rank (R) Author Number of published articles Cluster (number of co-authorships) Total citation (R) h-index (R) Country
1 Isolauri, E. 68 2 (82) 8873 (1) 35 (1) Finland
1 Szajewska, H. 68 5 (67) 3164 (4) 28 (3) Poland
3 Salminen, S. 53 2 (73) 7325 (2) 29 (2) Finland
4 Vandenplas, Y. 38 1 (10) 681 (10) 16 (6) Belgium
5 Neu, J. 29 7 (13) 1476 (7) 18 (4) USA
6 Walker, W.A. 26 7 (7) 1626 (6) 18 (4) USA
7 Guarino, A. 24 5 (16) 1064 (8) 14 (8) Italy
8 Korpela, R. 22 4 (33) 1662 (5) 13 (9) Finland
9 Kalliomaki, M. 21 2 (38) 3837 (3) 16 (6) Finland
10 Kuitunen, M. 19 4 (31) 1064 (8) 12 (10) Finland
R rank
Fig. 3 Co-authorship analysis for retrieved articles on probiotics in pediatric research (1994–2014)
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fact that non-academic institutions ranked among top
10 in probiotic research indicated that this topic is a very
interesting issue from a clinical, nutritional, econmic and
consumer aspects. In addition, research about probiotics
and its potential association with enhancing immunity
and combating allergy and asthma gave further momen-
tum to probiotic research in pediatrics [47, 67, 68].
Our results indicated that probiotics have been investi-
gated as a potential therapy to prevent and treat a wide
variety of pediatric ailments; mainly diarrhea, allergy, and
Table 6 Top 10 cited articles on probiotics in pediatrics (1994–2000) [33–42]
SCR Authors Title Year Source title Cited by
1st Majamaa &
Isolauri [39]
Probiotics: A novel approach in the management
of food allergy
1997 Journal of Allergy and Clinical Immunology 659
2nd Isolauri
et al. [38]
Probiotics in the management of atopic eczema 2000 Clinical and Experimental Allergy 638
3rd Björkstén
et al. [34]
The intestinal microflora in allergic Estonian and
Swedish 2-year-old children
1999 Clinical and Experimental Allergy 624
4th Collins &
Gibson [35]
Probiotics, prebiotics, and synbiotics: Approaches for
modulating the microbial ecology of the gut
1999 American Journal of Clinical Nutrition 502
5th Guandalini
et al. [36]
Lactobacillus GG administered in oral rehydration solution
to children with acute diarrhea: A multicenter European trial





Lactobacillus GG in the prevention of antibiotic-associated
diarrhea in children
1999 Journal of Pediatrics 358
7th Salminen [41] Clinical uses of probiotics for stabilizing the gut mucosal barrier:
Successful strains and future challenges
1996 Antonie van Leeuwenhoek, International





Prophylactic Lactobacillus GG reduces antibiotic-associated




Interleukin-10 generation in atopic children following oral
lactobacillus rhamnosus GG
2000 Clinical and Experimental Allergy 273
10th Hoyos [37] Reduced incidence of necrotizing enterocolitis associated with
enteral administration of Lactobacillus acidophilus and
Bifidobacterium infantis to neonates in an intensive care unit
1999 International Journal of Infectious Diseases 231
SCR standard competition ranking
Table 7 Top 10 cited articles on probiotics in pediatrics (2001–2007) [43–52]
SCR Authors Title Year Source title Cited by
1st Kalliomäki
et al. [46]
Probiotics in primary prevention of atopic disease:




Probiotics and prevention of atopic disease: 4-year




Probiotics: An overview of beneficial effects 2002 Antonie van Leeuwenhoek, International




Probiotics: Effects on immunity 2001 American Journal of Clinical Nutrition 495
5th D’Souza
et al. [43]
Probiotics in prevention of antibiotic associated diarrhoea:
Meta-analysis
2002 British Medical Journal 463
6th Van Niel
et al. [52]
Lactobacillus therapy for acute infectious diarrhea in children:
A meta-analysis
2002 Pediatrics 413
7th Lin et al.
[48]
Oral probiotics reduce the incidence and severity of necrotizing
enterocolitis in very low birth weight infants
2005 Pediatrics 401
8th Lin & Stoll
[49]
Necrotising enterocolitis 2006 Lancet 396
9th Rosenfeld
et al. [51]
Effect of probiotic Lactobacillus strains in children with
atopic dermatitis
2003 Journal of Allergy and Clinical Immunology 376
10th Hatakka
et al. [44]
Effect of long term consumption of probiotic milk on infections in
children attending day care centres: Double blind, randomised trial
2001 British Medical Journal 366
SCR standard competition ranking
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gastrointestinal problems such as infantile colic, functional
constipation, irritable bowel syndrome, ulcerative colitis,
necrotizing enterocolitis and prevention of dental caries.
Based on a recent literature review study, the most
common health applications for probiotics include diar-
rhea, prevention of allergies, and treatment of a wide
range of bowel diseases [3]. There is a general agreement
that probiotics are modestly effective in treatment or
prevention of acute infectious diarrhea [69, 70] but are of
a significant benefit in decreasing incidence of antibiotic-
associated diarrhea [71]. However, there is still inadequate
evidence to support routine use of probiotics in the
prevention of antibiotic-associated Clostridium difficile
infectious diarrhea or non-Clostridium difficile antibiotic
associated diarrhea [72, 73]. Studies regarding use of
probiotics in prevention or treatment of eczema showed
conflicting results and therefore, probiotics are not recom-
mended for routine use of eczema [1]. Probiotics are
currently marketed as dietary supplements and in infant
formulas and dairy foods such as yogurt and therefore no
Table 8 Top 10 cited articles on probiotics in pediatrics (2008–2014) [53–62]
SCR Authors Title Year Source title Cited by
1st Neu & Walker
[61]
Necrotizing enterocolitis 2011 New England Journal of Medicine 412
2nd Van Assche
et al. [62]
The second European evidence-based Consensus on the diagnosis
and management of Crohn’s disease: Special situations
2010 Journal of Crohn’s and Colitis 382
3rd Kalliomäki
et al. [57]
Early differences in fecal microbiota composition in children may
predict overweight





Enteral nutrient supply for preterm infants: Commentary from the
european society of paediatric gastroenterology, hepatology and
nutrition committee on nutrition





Bacterial metabolism and health-related effects of galacto-oligosaccharides
and other prebiotics
2008 Journal of Applied Microbiology 283
6th Deshpande
et al. [55]
Updated meta-analysis of probiotics for preventing necrotizing
enterocolitis in preterm neonates
2010 Pediatrics 274
7th Hsiao et al.
[56]
Microbiota modulate behavioral and physiological abnormalities




Diet, gut microbiota and immune responses 2011 Nature Immunology 261
9th Lin et al. [58] Oral probiotics prevent necrotizing enterocolitis in very low birth




Early dietary intervention with a mixture of prebiotic oligosaccharides
reduces the incidence of allergic manifestations and infections during
the first 2 years of life
2008 Journal of Nutrition 227
SCR standard competition ranking
Table 9 Top 10 list of institutions that published research articles on probiotics in pediatrics (1994–2015)
SCRa Institution Number of documents





H-index (Rank) Affiliation country
1st Turun yliopisto 82 (2.91) 8095 (1) 98.72 (2) 34 (1) Finland
2nd Medical University Warsaw 72 (2.56) 3234 (3) 44.92 (5) 27 (2) Poland
3rd Universita degli Studi di Napoli Federico II 45 (1.60) 1805 (6) 40.11 (8) 23 (3) Italy
4th Universita degli Studi di Milano 44 (1.56) 1864 (5) 42.36 (7) 19 (6) Italy
5th Massachusetts General Hospital 37 (1.31) 2105 (4) 56.89 (3) 22 (4) USA
6th Turun Yliopistollinen Keskussairaala 36 (1.28) 5103 (2) 141.75 (1) 21 (5) Finland
7th Universite Paris Descartes 35 (1.24) 1553 (7) 44.37 (6) 18 (7) France
8th Nestle 32 (1.14) 1072 (9) 33.50 (9) 17 (8) Switzerland
9th University of Florida 29 (1.03) 1410 (8) 48.62 (4) 16 (9) USA
9th Universitair Ziekenhuis Brussel 29 (1.03) 567 (10) 19.55 (10) 14 (10) Belgium
SCR standard competition ranking, USA United States of America
aEqual institutions have the same ranking number, and then a gap is left in the ranking numbers
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FDA approval is needed for their marketing. However,
other probiotic products such as those used in treatment
and/or prevention of a disease, are considered biologic
products, and are extensively reviewed and regulated by
the FDA [74].
Analysis of countries involved in probiotic research
related to pediatric therapies showed that the USA was
dominant in this field. This was not surprising given that
the USA ranked first in most worldwide bibliometric
analysis of various medical fields [75–77]. The sales of pro-
biotics in the USA grew by 31 % during 1 year and it is ex-
pected that annual sales to reach $31.1 billion by 2015 and
might even be better depending upon consumer’s educa-
tion and awareness of the safety and value of these products
[78]. The majority of top ranking countries and institutions
were European, probably due to advanced infant food in-
dustries in those particular European countries. Turun ylio-
pisto (i.e., University of Turku) in Finland had the greatest
share of publications, total citations and h-index value while
Turun Yliopistollinen Keskussairaala (Hospital District of
Southwest Finland) ranked first in average number of cita-
tions per article. Both institutions are in Finland. Further-
more half of the top prolific authors on probiotics in
pediatrics are from Finland. All this made Finland to rank
number one country in research activity on probiotics in
pediatrics when measured per population or per GDP. Un-
fortunately, none of the top ten countries or institutions
were from Latin America or Africa, or Middle East.
Publications from Finland showed dominant domestic
collaboration with one third being from international
collaboration which is lesser than that in UK or Germany
but higher than that in USA. International collaboration
in probiotic research and publication should be encouraged
and emphasized given that probiotics could be of great
value to children in developing countries were expensive
medications might not be available. Furthermore, colla-
boration increases the probability of citations independent
of time since publication, journal, or the country of the
author [79].
The top 10 cited articles over the past two decades
revealed that most of the hot articles were focused on the
role of probiotics in treatment of allergy and diarrhea in
children. The other ones were related to microbiology,
immunology and potential mechanism of benefits of pro-
biotics in children. No wonder that such hot articles were
mainly published in highly prestigious journals in the field
of allergy/ immunology, pediatrics, and general medicine.
Our study showed that the number of uncited articles
represents approximately 22 % which is considered high.
However, the number of citations of any article varies
from time to time and from one journal to another.
Therefore, comparison of uncited articles from one
subject to another might not be of great benefit.
Our study has a few limitations related to search strategy
and methodology [12, 15, 30, 32, 80, 81]. For example, our
study did not include articles published in non-Scopus
database. However, Scopus remain a reliable and large
source for bibliometric studies in general. Another limita-
tion in our study is the keywords strategy. False positive
and false negative results could be obtained regardless of
how accurate the search stagey was. However, with the
manual check of more than 300 articles, we believed that
false positive or negative results will be very marginal and
could hardly affect the accuracy of the results. Furthermore,
the use of the keywords in title search instead of title/ab-
stract/keywords would minimize false positive and negative
articles and keep non-relevant articles in the minimum tol-
erable number. To the best of our knowledge, this is the
Table 10 Top 10 list of journals in which research documents on probiotics in pediatrics were published






1st Journal of Pediatric Gastroenterology and
Nutrition
127 (4.51) 5496 43.27 42 2.625 (7)
2nd Pediatrics 61 (2.17) 4055 66.47 29 N/A (10)
3rd Journal of Pediatrics 50 (1.77) 2477 49.54 21 3.790 (3)
4th Pediatric Allergy and Immunology 39 (1.38 978 25.08 19 3.397 (6)
5th British Journal of Nutrition 37 (1.31) 1552 41.95 20 3.453 (5)
6th Journal of Clinical Gastroenterology 33 (1.17) 857 25.97 17 3.498 (4)
7th Clinical and Experimental Allergy 32 (1.14) 2574 80.44 19 4.769 (2)
8th Journal of Allergy and Clinical Immunology 27 (0.96) 3040 112.59 19 11.476 (1)
9th Pediatria Wspolczesna 24 (0.85) 47 1.96 4 0.00 (9)
9th Early Human Development 24 (0.85) 505 21.04 14 1.785 (8)
SCR standard competition ranking, N/A not available
aEqual journals have the same ranking number, and then a gap is left in the ranking numbers
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first bibliometric study on probiotics in general and in
pediatric in specific.
Conclusions
The results of our study showed the following characteris-
tics regarding probiotic publications: there is a growing
interest in this topic as seen by the linear increase in the
number of publications with time; there is a dominant
leadership for Finland and USA in pediatric probiotic pub-
lications; there is a wide variety of journal names in which
probiotics research is published; there is a great focus on
clinical therapeutic application of probiotics as demon-
strated by the title of hot articles in the field; and there is
a wide variation in inter-country collaboration in probiotic
research among the top leadership countries and there is a
common trend toward domestic different countries.
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